FIGURE 5.

SPAK inhibitor ZT‐1a prevents BCAS‐induced loss of both OPCs and OL in CC and EC. (A–C) Double‐immunofluorescence analysis of APC/NG2 in CC and EC, and caspase 3⁺/Olig2⁺ cells in CC of sham, Veh‐, and ZT‐1a‐treated brains at 5 weeks after BCAS surgery. The same cohort as Figure 4. Nuclei were counterstained with DAPI. Data are mean ± SEM; one‐way ANOVA, Tukey's post hoc test; n = 4, *p < 0.05, **p < 0.01.